Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 2, 1997, Pages 603-608

  Van Der Poll, Tom ^b   Keogh, Christopher V ^b   Buurman, Wim A ^b   Lowry, Stephen F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BLOOD LEVEL; CONTROLLED STUDY; HOST RESISTANCE; LOBAR PNEUMONIA; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0031045654     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.2.9032201     Document Type: Article

References (33)

1. Garibaldi, R. A. 1985. Epidemiology of community-acquired respiratory tract infection in adults: incidence, etiology, and impact. Am. J. Med. 78:S32-S37.
2. American Thoracic Society. 1993. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am. Rev. Respir. Dis. 148:1418-1426.
3. Bates, J. H., G. D. Campbell, A. L. Barron, G. A. McCracken, P. N. Morgan, E. B. Moses, and C. M. Davis. 1992. Microbial etiology of acute pneumonia in hospitalized patients. Chest 101:1005-1012.
4. Marrie, T. J., H. Durant, and L. Yates. 1989. Community-acquired pneumonia requiring hospitalization: a 5 year prospective study. Rev. Infect. Dis. 11:586-599.
5. Torres, A., J. Serra-Batlles, A. Ferrer, P. Jimenez, R. Celis, E. Cobo, and R. Rodriguez-Roisin. 1991. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am. Rev. Respir. Dis. 144:312-318.
6. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Micobiol. Rev. 3:171-196.
7. Friedland, I. R., and G. H. McCracken. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
8. Van der Poll, T., and S. F. Lowry. 1995. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 3:1-12.
9. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664.
10. Hinshaw, L. B., P. Tekamp-Olson, A. C. K. Chang, P. A. Lee, F. B. Taylor, Jr., C. K. Murray, G. T. Peer, T. E. Emerson, R. B. Passey, and G. C. Kuo. 1990. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNFα). Circ. Shock 30:279-292.
11. Kolls, J. K., D. Lei, S. Nelson, W. R. Summer, S. Greenberg, and B. Beutler. 1995. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J. Infect. Dis. 171:570-575.
12. Gosselin, D., J. DeSanctis, M. Boulé, E. Skamene, C. Matouk, and D. Radzioch. 1995. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun. 63:3272-3278.
13. Brieland, J. K., D. G. Remick, P. T. Freeman, M. C. Hurley, J. C. Fantone, and N. C. Engleberg. 1995. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect. Immun. 63:3253-3258.
14. Sheehan, K. C. F., N. H. Ruddle, and R. D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factor. J. Immunol. 142:3884-3889.
15. Leeuwenberg, J. F. M., J. Van Damme, A. Meager, G. M. A. A. Jeunhomme, and W. A. Buurman. 1988. Effects of tumor necrosis factor on the interferon-γ-induced major histocompatibility complex class II antigen expression by human endothelial cells. Eur. J. Immunol. 18:1469-1472.
16. Van der Poll, T., A. Marchant, W. A. Buurman, L. Berman, C. V. Keogh, D. D. Lazarus, L. Nguyen, M. Goldman, L. L. Moldawer, and S. F. Lowry. 1995. Endogenous interleukin 10 protects mice from death during septic peritonitis. J. Immunol. 155:5397-5401.
17. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-109.
18. Goldblum, S. E., K. M. Wu, and M. Jay. 1985. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J. Appl. Physiol. 59:1978-1985.
19. Koike, K., F. A. Moore, E. E. Moore, R. A. Read, V. S. Carl, and A. Banerjee. 1993. Gut ischemia mediates lung injury by a xanthine oxidase-dependent neutrophil mechanism. J. Surg. Res. 54:469-473.
20. Fong, Y., K. J. Tracey, L. L. Moldawer, D. G. Hesse, K. R. Manogue, J. S. Kenney, A. T. Lee, G. C. Kuo, A. C. Allison, S. F. Lowry, and A. Cerami. 1989. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170:1627-1633.
21. Van der Poll, T., M. Levi, S. J. H. van Deventer, H. ten Cate, B. L. Haagmans, B. J. Biemond, H. R. Büller, C. E. Hack, and J. W. ten Cate. 1994. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 83:446-451.
22. Van der Poll, T., J. Jansen, M. Levi, H. ten Cate, J. W. ten Cate, and S. J. H. van Deventer. 1994. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J. Exp. Med. 180:1985-1988.
23. Van der Poll, T., M. Levi, H. ten Cate, J. Jansen, B. J. Biemond, B. L. Haagmans, A. Eerenberg, S. J. H. van Deventer, C. E. Hack, and J. W. ten Cate. 1995. Effect of postponed treatment with an anti-tumour necrosis factor F(ab′)2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees. Clin. Exp. Immunol. 100: 21-25.
24. Heidbrink, P. J., S. R. Rehm, G. B. Toews, and A. K. Pierce. 1980. Granulocyte participation in early clearance of pneumococci from the murine lung. Am. Rev. Respir. Dis. 121:S351.
25. Kolls, J. K., S. Nelson, and W. R. Summer. 1993. Recombinant cytokines and pulmonary host defense. Am. J. Med. Sci. 306:330-335.
26. Buret, A., M. L. Dunkley, G. Pang, R. L. Clancy, and A. W. Cripps. 1994. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats: roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1α. Infect. Immun. 62:5335-5343.
27. Blanchard, D. K., J. Y. Djeu, T. W. Klein, H. Friedmann, and W. E. Stewart, II. 1988. Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J. Leukocyte Biol. 43:429-435.
28. Ferrante, A., A. J. Martin, E. J. Bates, D. H. B. Goh, D. P. Harvey, D. Parsons, D. A. Rathjen, G. Russ, and J. Dayer. 1993. Killing of Staphylococcus aureus by tumor necrosis factor-α-activated neutrophils: the role of opsonins, integrin receptors, respiratory burst, and degranulation. J. Immunol. 151:4821-4827.
29. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155:722-729.
30. Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gérard, A. Delvaux, D. de Groote, D. Abramowicz, T. Velu, and M. Goldman. 1994. IL-10 controls IFN-γ and TNF production during experimental endotoxemia. Eur. J. Immunol. 24:1167-1171.
31. Bagby, G. J., K. J. Plessala, L. A. Wilson, J. J. Thompson, and S. Nelson. 1991. Divergent efficacy of antibody to tumor necrosis factor-α in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163: 83-88.
32. Echtenacher, B., W. Falk, D. N. Männel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762-3766.
33. Havell, E. A. 1989. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143:2894-2899.